No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
CLDX Celldex Therapeutics
- 19.560
- -1.110-5.37%
Close Mar 10 16:00 ET
- 19.560
- 0.0000.00%
Post 20:01 ET
1.30BMarket Cap-7.98P/E (TTM)
21.000High19.470Low743.81KVolume20.400Open20.670Pre Close14.82MTurnover1.22%Turnover RatioLossP/E (Static)66.38MShares47.00052wk High1.74P/B1.20BFloat Cap18.61052wk Low--Dividend TTM61.14MShs Float3374.997Historical High--Div YieldTTM7.40%Amplitude1.500Historical Low19.922Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Celldex Therapeutics Insiders Sold US$2.1m Of Shares Suggesting Hesitancy
Celldex Therapeutics to Present at Upcoming Investor Conferences
Atopic Dermatitis: 2025 Pipeline Insights Report Covering 100+ Companies and 120+ Pipeline Drugs, Including ICP-332 (Innocare Pharma), APG777 (Apogee Therapeutics), and Barzolvolimab (Celldex Therapeutics)
Celldex Therapeutics Is Maintained at Neutral by Goldman Sachs
Celldex Therapeutics Reports Positive Preclinical Data For Inflammation Drug
Celldex Therapeutics Shares Are Trading Higher After the Company Presented Preclinical Data for CDX-622 at AAAAI 2025.
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.